We need to engage more, explain the system, and clarify the steps that we are taking
In Conversation
After almost 20 years of work, [the implementation of EU HTA legislation] will finally become a reality in 2025 with joint work on scientific consultations, clinical…
Sweden has many startups and biotechnology companies, which offers a great window of opportunity for PPD to contribute to the regional industry's R&D efforts
Many people in the industry were worried about what would happen if all phase I studies disappeared from Sweden, and in retrospect, I have realized how…
KLIFO understands that small companies need knowledge and senior advice on the best route to market for their specific drugs.
The biopharmaceutical industry is continuously changing and we realize how important it is to support our customers throughout their clinical development journey.
I am very proud of the Swedish affiliate, as we have a leadership position in most of our treatment areas, due to our strong performance in…
It is only by getting close to the care setting, the patients and the caregivers that we can create truly meaningful innovation
Today we have a strong presence in almost every country in Western Europe and a significant footprint in India, where we made two acquisitions, while we…
Sweden is a worldwide leader in approaching value-based healthcare, as we have the right building blocks with the quality registries, the integrated care solutions and the…
There is a five-billion-dollar market for biological drugs in ulcerative colitis that in fact has a lot of room for growth
[Sweden] still remains a top destination for new treatments, especially if a company is working with a revolutionary therapy
